Stereotaxis rises on partnership with Abbott on medical robotic

Stereotaxis

19/05/2023 17:59

** Shares of surgical robotics co Stereotaxis Inc  STXS.A 
rise 26.6% to $2.14
    ** Co announces global collaboration with Abbott
Laboratories  ABT.N  to integrate its robotic magnetic
navigation systems with Abbott's 3D mapping platform
    ** STXS stock set to post best day since Feb. 25, 2021 if
gains hold
    ** Says collaboration will help bringing highly detailed
real-time diagnostic information to improve treatment of
abnormal heart rhythms
    ** Adds their integrated technologies are cleared for use in
Europe with additional regulatory clearances expected in coming
months
    ** Including session gains, stock up 4.83% YTD

 (Reporting by Sruthi Narasimha Chari in Bengaluru)
 ((Sruthinarasimha.chari@thomsonreuters.com))